Prospective Analysis: Relative Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors

BACKGROUND: Tyrosine kinase inhibitors (TKIs) improved overall survival (OS) in patients with chronic myeloid leukemia in chronic phase (CML-CP). The purpose of this study was to compare OS in patients with newly diagnosed CML-CP to that of general population. METHODS: Response and survival data in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Koji, Strom, Sara S., O’Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Konopleva, Marina, Borthakur, Gautam, Pemmaraju, Naveen, Daver, Naval, Jain, Preetesh, Pierce, Sherry, Kantarjian, Hagop, Cortes, Jorge E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884053/
https://www.ncbi.nlm.nih.gov/pubmed/26688093
http://dx.doi.org/10.1016/S2352-3026(15)00048-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884053/
https://www.ncbi.nlm.nih.gov/pubmed/26688093
http://dx.doi.org/10.1016/S2352-3026(15)00048-4

Ejemplares similares